CDS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.745600E-01
Normal-vs-Stage2
4.948400E-01
Normal-vs-Stage3
2.859800E-02
Normal-vs-Stage4
3.267800E-01
Stage1-vs-Stage2
1.355640E-01
Stage1-vs-Stage3
5.506200E-02
Stage1-vs-Stage4
2.949000E-01
Stage2-vs-Stage3
6.824200E-02
Stage2-vs-Stage4
7.247600E-01
Stage3-vs-Stage4
1.830990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.315600E-01
Normal-vs-AfricanAmerican
6.783400E-01
Normal-vs-Asian
2.793000E-01
Caucasian-vs-AfricanAmerican
9.241600E-01
Caucasian-vs-Asian
3.705800E-01
AfricanAmerican-vs-Asian
4.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.276000E-01
Normal-vs-Female
7.178200E-01
Male-vs-Female
9.435000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.987400E-01
Normal-vs-Age(41-60Yrs)
9.027600E-01
Normal-vs-Age(61-80Yrs)
7.145000E-01
Normal-vs-Age(81-100Yrs)
8.121800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.083400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.068000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.247600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.271600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.181100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.091160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.573180E-01
Normal-vs-Daily Drinker
4.906600E-01
Normal-vs-Weekly Drinker
5.940200E-01
Normal-vs-Occasional Drinker
8.375200E-01
Normal-vs-Social Drinker
9.754600E-01
Non Drinker-vs-Daily Drinker
4.638600E-01
Non Drinker-vs-Weekly Drinker
1.841010E-01
Non Drinker-vs-Occasional Drinker
6.522400E-02
Non Drinker-vs-Social Drinker
1.852050E-02
Daily Drinker-vs-Weekly Drinker
6.493800E-01
Daily Drinker-vs-Occasional Drinker
1.730570E-01
Daily Drinker-vs-Social Drinker
1.940190E-01
Weekly Drinker-vs-Occasional Drinker
2.982000E-01
Weekly Drinker-vs-Social Drinker
3.904400E-01
Occasional Drinker-vs-Social Drinker
6.900800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.352400E-01
Normal-vs-Grade 2
1.447650E-01
Normal-vs-Grade 3
1.036610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.932400E-01
Grade 1-vs-Grade 3
3.891400E-01
Grade 1-vs-Grade 4
4.352400E-01
Grade 2-vs-Grade 3
5.821600E-01
Grade 2-vs-Grade 4
1.447650E-01
Grade 3-vs-Grade 4
1.036610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.933600E-01
Normal-vs-NonDiabetic
8.326200E-01
Diabetic-vs-NonDiabetic
5.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.252400E-01
Normal-vs-NoPancreatitis
8.248000E-01
Pancreatitis-vs-NoPancreatitis
4.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.923400E-01
Normal-vs-N1
5.458600E-01
N0-vs-N1
5.552400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.885200E-01
Normal-vs-TP53-NonMutant
9.147600E-01
TP53-Mutant-vs-TP53-NonMutant
1.060750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
